Malignant Ascites after Subduroperitoneal Shunt in a Patient with Leptomeningeal Metastasis.
Min Ho Lee, Jung Il Lee
J Korean Neurosurg Soc. 2011;50(4):385-387.     DOI: https://doi.org/10.3340/jkns.2011.50.4.385
Citations to this article as recorded by Crossref logo
Ventriculoperitoneal shunting with an on–off valve for patients with leptomeningeal metastases and intracranial hypertension
Kristin M Huntoon, Jaime Gasco, Isabella C Glitza Oliva, Sherise D Ferguson, Nazarin K Majd, Ian E McCutcheon
Neuro-Oncology Practice.2023;[Epub]     CrossRef
Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions
Isabella C. Glitza, Keiran S. M. Smalley, Priscilla K. Brastianos, Michael A. Davies, Ian McCutcheon, James K. C. Liu, Kamran A. Ahmed, John A. Arrington, Brittany R. Evernden, Inna Smalley, Zeynep Eroglu, Nikhil Khushalani, Kim Margolin, Harriet Kluger,
Pigment Cell & Melanoma Research.2020; 33(4): 527.     CrossRef
A brainstem mass of Müllerian type Epithelial Origin without any primary cancer source
Brian Fiani, Syed A. Quadri, Mudassir Farooqui, Massimo D'Apuzzo, Robert J. Rosser, Blake W. Berman, Jerry Noel, Xin S. Xin, Behnam Badie, Anirudh Ramachandran, Javed Siddiqi
Journal of Clinical Neuroscience.2019; 59: 325.     CrossRef
Palliative shunt surgery for patients with leptomeningeal metastasis
Yuta Murakami, Masahiro Ichikawa, Mudathir Bakhit, Shinya Jinguji, Taku Sato, Masazumi Fujii, Jun Sakuma, Kiyoshi Saito
Clinical Neurology and Neurosurgery.2018; 168: 175.     CrossRef
Surgical Treatment for Leptomeningeal Disease
Andrey A. Volkov, Andreas K. Filis, Frank D. Vrionis
Cancer Control.2017; 24(1): 47.     CrossRef